The role of prognostic nutritional index in the management of pulmonary sarcomatoid carcinoma

ConclusionThe PNI and the pathological TNM stage are independent prognostic factors for pulmonary sarcomatoid carcinoma. PNI is an important indicator for the selection of postoperative adjuvant therapy. Patients with PNI  ≥ 49.4 may benefit from postoperative chemotherapy and targeted therapy. We still need further prospective studies to confirm these results.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research